4.4 Article

Lipid and non-lipid cardiovascular risk factors in postmenopausal type 2 diabetic women with and without coronary heart disease

Journal

JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION
Volume 37, Issue 3, Pages 261-268

Publisher

SPRINGER
DOI: 10.1007/s40618-013-0023-z

Keywords

Creatine clearance; SdLDL; Coronary heart disease; Type 2 diabetes; Women

Ask authors/readers for more resources

Background Coronary heart disease (CHD) is the leading cause of death in diabetic women. In addition to hyperglycemia, other factors may contribute to the excessive cardiovascular risk. Aim In this study we evaluated common and emerging risk factors in a selected group of postmenopausal type 2 diabetic women with (n = 36) and without CHD (n = 59), not taking lipid-lowering medications. Methods Clinical and lifestyle data were collected, and metabolic and lipid profile, as well as fasting plasma levels of total homocysteine (tHcy), folate, vitamin B12, C-reactive protein (hsCRP), interleukin 6 (IL-6), and vascular cell adhesion molecule-1 (VCAM-1) were measured in all participants. Results Age, menopause and diabetes duration, family history for cardiovascular disease, prevalence of hypertension and current insulin use were greater in diabetic women with than without CHD (P < 0.05 for all comparisons). CHD women also showed higher levels of triglycerides, small dense LDL (sdLDL), remnant-like particle cholesterol, tHcy, and VCAM-1, and a lower creatinine clearance (P < 0.05 all). Conversely, the two groups were comparable for BMI, waist circumference, smoking habit, fasting plasma glucose, HbA(1c), total cholesterol, low-density lipoprotein cholesterol (LDL-C), HDL cholesterol, folate, vitamin B12, hsCRP and IL-6 levels. At multivariate analysis, lower creatinine clearance (OR = 0.932, P = 0.017) and higher sdLDL serum concentration (OR = 1.224, P = 0.037) were the strongest risk factors associated with CHD in this population, whereas no significant association was noted with LDL-C. Conclusions Our data suggest that beyond LDL-C, a lower creatinine clearance and more subtle alterations of LDL particles, together with a constellation of several well known and emerging cardiovascular risk factors, are stronger contributors to the high CHD risk of diabetic women.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Neurosciences

Pimozide and pancreatic cancer in diabetic chorea: a case report

Carmelo Tiberio Curro, Giulia Nicocia, Vanessa Ziccone, Antonio Ciacciarelli, Giuseppina Russo, Antonio Toscano, Carmen Terranova, Paolo Girlanda

Summary: This case report describes a 70-year-old female patient with diabetic chorea, who benefitted from pimozide treatment but later died of pancreatic cancer. The patient initially presented with symptoms of choreic movements and high blood sugar, and despite various treatments, only pimozide proved effective in managing her symptoms. The diagnosis of pancreatic cancer several months after the onset of chorea suggests a potential causal link between the two conditions.

INTERNATIONAL JOURNAL OF NEUROSCIENCE (2022)

Article Endocrinology & Metabolism

Underestimation of hypoglycaemia using patients' diaries compared with downloaded glucometer data: an ITAS post hoc analysis

Raffaella Buzzetti, Riccardo C. Bonadonna, Andrea Giaccari, Gianluca Perseghin, Domenico Cucinotta, Carmine Fanelli, Angelo Avogaro, Gianluca Aimaretti, Monica Larosa, Ilaria Pacchetti, Geremia B. Bolli

DIABETES OBESITY & METABOLISM (2022)

Article Clinical Neurology

Ischemic stroke and reperfusion therapies in diabetic patients

Carmelo Tiberio Curro, Giulia Fiume, Masina Cotroneo, Giuseppina Russo, Carmela Casella, Cristina Dell'Aera, Maria Carolina Fazio, Francesco Grillo, Angelina Lagana, Giuseppe Trimarchi, Antonio Toscano, Sergio Lucio Vinci, Rosa Fortunata Musolino, Paolino La Spina

Summary: This study aimed to explore the main prognostic factors in diabetic patients undergoing reperfusion therapies for ischemic stroke. The results showed that glycemia and neurological severity were associated with prognosis in intravenous thrombolysis, while age, glycemia, and systolic pressure were associated with prognosis in mechanical thrombectomy. Additionally, the study found that metformin had a protective effect in intravenous thrombolysis, and weight and treatment duration were associated with prognosis in mechanical thrombectomy.

NEUROLOGICAL SCIENCES (2022)

Article Cardiac & Cardiovascular Systems

CAPTURE: A cross-sectional study on the prevalence of cardiovascular disease in adults with type 2 diabetes in Italy

Giuseppina T. Russo, Gerardo Corigliano, Franco Arturi, Maria Gisella Cavallo, Cristiano Bette, Edoardo Mannucci

Summary: This study investigated the prevalence and treatment of cardiovascular diseases in Italian patients with type 2 diabetes. The results showed that more than one-third of patients had cardiovascular diseases, but the majority of them were not receiving the recommended medications according to national and international guidelines.

NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES (2022)

Article Biochemistry & Molecular Biology

Sex-Specific Impact of Different Obesity/Metabolic Phenotypes on Long-Term Cardiovascular Outcomes in Acute Coronary Syndrome Patients

Egidio Imbalzano, Giuseppina T. Russo, Annalisa Giandalia, Angela Sciacqua, Luana Orlando, Vincenzo Russo, Maria Perticone, Arrigo F. G. Cicero, Antonio Giovanni Versace, Pierpaolo Di Micco, Vincenzo Antonio Ciconte, Giuseppe Dattilo, Giovanni Squadrito, Marco Vatrano

Summary: This study evaluated the long-term cardiovascular risk in acute coronary syndrome patients based on different obesity/metabolic phenotypes and sex. The results showed that the impact of obesity phenotypes on cardiovascular risk varies between men and women.

BIOMEDICINES (2022)

Article Medicine, General & Internal

The SIMI Gender '5 Ws' Rule for the integration of sex and gender-related variables in clinical studies towards internal medicine equitable research

Valeria Raparelli, Francesca Santilli, Alberto Maria Marra, Giulio Francesco Romiti, Elena Succurro, Anna Licata, Elena Buzzetti, Salvatore Piano, Maristella Masala, Patrizia Suppressa, Cecilia Becattini, Maria Lorenza Muiesan, Giuseppina Russo, Chiara Cogliati, Marco Proietti, Stefania Basili

Summary: Biological sex and sociocultural gender are important factors in health and diseases, and should be considered in clinical studies. The Gender Working Group of the Italian Society of Internal Medicine (SIMI) has provided a practical framework for internal medicine specialists to integrate gender considerations into their research and clinical practice. This framework, known as the SIMI Gender '5 Ws' Rule, provides guidelines for who, what, where, when, and why gender-related variables should be included in clinical studies.

INTERNAL AND EMERGENCY MEDICINE (2022)

Article Endocrinology & Metabolism

A prediction model to assess the risk of egfr loss in patients with type 2 diabetes and preserved kidney function: The amd annals initiative

G. T. Russo, A. Giandalia, A. Ceriello, P. Di Bartolo, G. Di Cianni, P. Fioretto, C. B. Giorda, V. Manicardi, R. Pontremoli, F. Viazzi, G. Lucisano, A. Nicolucci, S. De Cosmo

Summary: In this study, a predictive model for eGFR loss in type 2 diabetes patients was developed and validated. The model showed good performance in identifying patients at risk of developing clinically significant renal complications within a 5-year timeframe.

DIABETES RESEARCH AND CLINICAL PRACTICE (2022)

Review Cardiac & Cardiovascular Systems

Sex- and gender-differences in chronic long-term complications of type 1 and type 2 diabetes mellitus in Italy

G. T. Russo, V. Manicardi, M. C. Rossi, E. Orsi, A. Solini

Summary: This review summarizes the contributions of Italian diabetologists to studying the complex relationship between sex/gender and long-term complications of type 1 and type 2 diabetes over the last fifteen years. It highlights the impact of sex- and gender-related differences on diabetes complications and the lack of consideration of such differences in current clinical guidelines.

NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES (2022)

Article Environmental Sciences

Long-Term Influence of Locus of Control and Quality of Life on Metabolic Profile in Elderly Subjects with Type 2 Diabetes

Annalisa Giandalia, Marta Ragonese, Eugenio Alessi, Maria C. Ruffo, Alberto Sardella, Alessandro Cuttone, Maria A. Aragona, Antonio G. Versace, Giorgio Basile, Domenico Cucinotta, Giovanni Squadrito, Giuseppina T. Russo

Summary: This study aimed to evaluate the predictive role of LOC and QoL scores on metabolic control in elderly T2D outpatients and found potential gender differences. The results showed that LOC scores may influence long-term glycemic control in elderly T2D patients.

INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH (2022)

Article Urology & Nephrology

Association of renal function screening frequency with renal function decline in patients with type 2 diabetes: a real-world study in primary health care

Henry Sundqvist, Eveliina Heikkala, Jari Jokelainen, Giuseppina Russo, Ilona Mikkola, Maria Hagnas

Summary: This study examines the association between the screening frequency of estimated glomerular filtration rate (eGFR) and the substantial reduction in eGFR among type 2 diabetes patients. The study emphasizes the importance of regular eGFR screening in the prevention of kidney function decline.

BMC NEPHROLOGY (2022)

Article Endocrinology & Metabolism

The Burden of Obesity in Type 1 Diabetic Subjects: A Sex-specific Analysis From the AMD Annals Initiative

Annalisa Giandalia, Giuseppina Tiziana Russo, Patrizia Ruggeri, Annalisa Giancaterini, Elisabetta Brun, Mariarosaria Cristofaro, Anna Bogazzi, Maria Chiara Rossi, Giuseppe Lucisano, Alberto Rocca, Valeria Manicardi, Paolo Di Bartolo, Graziano Di Cianni, Chiara Giuliani, Angela Napoli

Summary: This study investigated the prevalence of obesity and severe obesity, clinical correlates, and potential sex differences in a large cohort of T1D subjects in Italy. The results showed that obesity was similar between men and women, but severe obesity was more prevalent among women. Obesity was associated with a higher burden of cardiovascular disease risk factors and complications, and a lower quality of care, with no major sex differences.

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2023)

Article Medicine, General & Internal

High Prevalence of Severe Hepatic Fibrosis in Type 2 Diabetic Outpatients Screened for Non-Alcoholic Fatty Liver Disease

Clelia Asero, Annalisa Giandalia, Irene Cacciola, Carmela Morace, Giuseppe Lorello, Amalia Rita Caspanello, Angela Alibrandi, Giovanni Squadrito, Giuseppina T. Russo

Summary: This study aimed to evaluate the occurrence and severity of liver fibrosis in type 2 diabetes outpatients without a known history of liver disease, and to identify predictive factors. The results showed that obesity, high triglycerides, worse glycemic control, and high creatinine levels were independent predictors of liver fibrosis in type 2 diabetes patients.

JOURNAL OF CLINICAL MEDICINE (2023)

Review Health Care Sciences & Services

Impact of Sex and Gender on Clinical Management of Patients with Advanced Chronic Liver Disease and Type 2 Diabetes

Anna Licata, Giuseppina T. Russo, Annalisa Giandalia, Marcella Cammilleri, Clelia Asero, Irene Cacciola

Summary: In recent years, there has been increasing reports on gender differences in the epidemiology, pathophysiological mechanisms and clinical features of chronic liver diseases associated with type 2 diabetes (T2D). This sexual dimorphism is influenced by a complex interaction between sex- and gender-related factors. However, the impact of sex and gender on the management of T2D subjects with liver disease is still unclear. Therefore, it is important to consider sex-related differences in pharmacology in order to improve drug safety and optimize medical therapy in both men and women with T2D.

JOURNAL OF PERSONALIZED MEDICINE (2023)

Article Endocrinology & Metabolism

Comparative effectiveness and safety of glargine 300 U/mL versus degludec 100 U/mL in insulin-naive patients with type 2 diabetes. A multicenter retrospective real-world study (RESTORE-2 NAIVE STUDY)

Gian Paolo Fadini, Raffaella Buzzetti, Antonio Nicolucci, Monica Larosa, Maria Chiara Rossi, Domenico Cucinotta

Summary: This study assessed the comparative effectiveness of Gla-300 and Deg-100 in insulin-naive patients with T2D. The results showed similar improvements in glycemic control, no weight gain, and low hypoglycemia rates without severe episodes for both treatments.

ACTA DIABETOLOGICA (2022)

No Data Available